Founded in 1923 out of a passion to help people with diabetes, Novo Nordisk’s aspiration is to improve awareness, prevention, detection and treatment of diabetes - and ultimately, to find a cure.
Obesity and weight management
At Novo Nordisk, we are committed to improving the understanding and management of obesity as a disease.
Haemophilia is an inherited (congenital) bleeding disorder in which the proteins required for blood to clot are partly or completely missing.
Growth hormone is important in helping children grow. It is also plays a role in the overall health of children and adults. Novo Nordisk is committed to helping patients with growth-related hormone disorders.
UK/WB/0515/0011(1) April 2017